| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.21 | 0.3 |